RMD

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Resmed Inc.

ResMed pioneers innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Its comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, the company improves quality of life, reduces the impact of chronic disease, and lowers costs for consumers and healthcare systems in more than 140 countries.
CEO
Michael Farrell
Employees
7770
Headquarters

9001 Spectrum Center Blvd
San Diego, California 92123-1438
Phone: 18587462400
www.resmed.com

News

ResMed Inc.: ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
Nov 22, 2022 14:05pm

- Acquisition expands ResMed''s SaaS business to Germany, first non-U.S. market - Outpatient therapy services added to ResMed''s growing SaaS offering portfolio - Purchase price of €958.6 million (US…


Source:Finanz Nachrichten
ResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
Nov 22, 2022 14:01pm

– Acquisition expands ResMed’s SaaS business to Germany, first non-U.S. market – Outpatient therapy services added to ResMed’s growing SaaS offering portfolio – Purchase price of €958.6 million (US$997.5 million); deal will be accretive to non-GAAP diluted earnings per share SAN DIEGO and HILDESHEIM, Germany, Nov. 22, 2022 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) today […]


Source:Financial Post
ResMed appoints Sandeep Gulati as General Manager, South Asia
Nov 16, 2022 06:55am

In his new role, Sandeep will be responsible for further growth in the Indian market and ensuring that there is increased awareness about sleep and respiratory disorders, the company said.


Source:The Financial Express
ResMed Inc. Lets Investors Breath Easy (NYSE:RMD)
Nov 14, 2022 04:37am

ResMed''s revenue is growing consistently. Read why owning RMD shares at a good price will let retail value investors sleep soundly.


Source:Seeking Alpha
ResMed: Strong Earnings Growth Supports The High Valuation, Unclear Technical Trends (RMD)
Nov 14, 2022 00:42am

U.S. medical device equities have not been a source of safety or growth in 2022. See why I''d like to wait on RMD stock to see how it behaves.


Source:Seeking Alpha
Petroleum Marketing Group Acquires Holt Oil Co.
Nov 09, 2022 00:00am

Holt Oil Co. sold its 19 petroleum marketing and convenience retail stores and wholesale dealer business to Petroleum Marketing Group Inc. (PMG). Holt Oil Co. is a third-generation, family-owned and -operated business with roots in Fayetteville, N.C. In 1930, William D. Holt founded Holt’s predecessor entity Crystal Oil Co. in downtown Fayetteville, N.C. The company…


Source:WTWH
Enhancements Have The Tuxedo Club Dressed to the Nines
Nov 09, 2022 00:00am

Renovations to the 18-hole golf course at the Tuxedo Park, N.Y. club, along with facilitated maintenance inputs, has the property looking and playing its best.


Source:WTWH
Calyx Peak Inc. Debuts Cultivation and Extraction Facility
Nov 09, 2022 00:00am

Calyx Peak Inc. has officially announced the opening of its new 82,500 square foot cultivation and extraction facility in Missouri. This new facility will vertically integrate Local Cannabis Company’s flagship location in the state, located at 1004 W. 45th St., Kansas City, Mo. 64111 at the corner of Belleview and West 45th Street in the heart of West Plaza. “We…


Source:WTWH
Sigma Additive Solutions announces launch of software for standardizing machine health data logs
Nov 08, 2022 00:00am

Sigma Additive Solutions, Inc., a leading developer of quality assurance software for the commercial 3D printing industry, announced that it is releasing a beta version of the PrintRite3D Machine Health module. This new solution marks the beginning of the company’s software-only approach to quality assurance by allowing users to take disparate machine log files and […]


Source:WTWH
Wawa Announces College Athletics Sponsorship
Nov 08, 2022 00:00am

Wawa announced its designation as the official hoagie of the Miami Hurricanes and the UCF Knights and proud partner of the Florida Gators and the Florida State Seminoles as part of its first-ever college athletics sponsorship of these four Florida universities. “Wawa just celebrated its 10th anniversary in the Sunshine State and as we continue to…


Source:WTWH
How are these ASX healthcare shares performing?
Nov 02, 2022 06:05am

Highlights: Healthcare can be recognised as the efforts made towards restoring or maintaining an individual’s normal physical, mental, and emotional state by licensed professionals. The Australian government claims to offer one of the best healthcare systems in the world, ensuring good-quality and safe healthcare for its citizens. Healthcare represents the provision of medical care given to an individual or a community in an organised manner. It is the effort by licensed professionals to help maintain or restore the normal physical, mental, and emotional state of an individual. The Australian government claims to offer one of the best healthcare systems in the world, offering good-quality, safe, and affordable healthcare provisions to its citizens. In this article, we feature three ASX-listed healthcare companies and their performance on the ASX today: CSL Limited ( ASX:CSL ), ResMed Inc ( ASX:RMD ), and PolyNovo Limited ( ASX:PNV ). CSL Limited (ASX:CSL) Shares of the healthcare giant CSL Limited (ASX:CSL) were spotted trading on a positive note on the ASX on Wednesday (2 November) afternoon.


Source:Kalkine Media
Citi Downgrades ResMed to Neutral
Oct 31, 2022 08:03am

https://www.investing.com/news/pro/citi-downgrades-resmed-to-neutral-432SI-2926376


Source:Investing.com
ResMed Inc. – Consensus Indicates Potential 9.5% Upside
Oct 30, 2022 13:47pm

ResMed Inc. with ticker code (RMD) now have 7 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 276 and 222 with the average target price sitting at 254.29. Now with the previous closing price of 232.29 this would indicate that there is a potential upside of 9.5%. There is a 50 day moving average of 222.87 while the 200 day moving average is 226.22. The company has a market capitalisation of $32,040m. You can visit the company''s website by visiting: https://www.resmed.com [stock_market_widget type="chart" template="basic" color="green" assets="RMD" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $35,075m based on the market concensus. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.


Source:DirectorsTalk
ResMed shares fall 6% despite reporting FQ1 2023 revenue growth
Oct 28, 2022 19:10pm

ResMed (RMD) stock slumped as much as 9.9% on Friday, despite the medical device company reporting a rise in quarterly revenue on the back of strong sales growth in the Americas


Source:Seeking Alpha
ResMed PT Raised to $280 at KeyBanc
Oct 28, 2022 08:05am

https://www.investing.com/news/pro/resmed-pt-raised-to-280-at-keybanc-432SI-2924856


Source:Investing.com
Why Brainchip, Calix, Fortescue, and ResMed shares are sinking
Oct 28, 2022 04:16am

These ASX shares sinking on Friday… The post Why Brainchip, Calix, Fortescue, and ResMed shares are sinking appeared first on The Motley Fool Australia .


Source:The Motley Fool Australia
ResMed Inc. (RMD) Q1 2023 Results - Earnings Call Transcript
Oct 28, 2022 01:13am

ResMed Inc. (NYSE:NYSE:RMD) Q1 2023 Earnings Conference Call October 27, 2022, 04:30 PM ET Company Participants Amy Wakeham - VP, IR & Corporate Communications Mick Farrell - CEO &…


Source:Seeking Alpha
Why is the ResMed share price sinking 6% on Friday?
Oct 28, 2022 00:40am

The ResMed Inc (ASX:RMD) share price is sinking on Friday following the release of the company''s first quarter update…


Source:The Motley Fool Australia
ResMed Inc. 2023 Q1 - Results - Earnings Call Presentation (NYSE:RMD)
Oct 28, 2022 00:06am

The following slide deck was published by ResMed Inc.


Source:Seeking Alpha
RMD stock raised to Buy at BofA citing Q1 beat (NYSE:RMD)
Oct 20, 2022 14:07pm

Bank of America upgraded medical device maker ResMed Inc


Source:Seeking Alpha
This Insider Just Sold Shares of ResMed Inc
Oct 18, 2022 19:30pm

Related Stocks: RMD ,


Source:GuruFocus
ResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
Oct 13, 2022 20:05pm

SAN DIEGO, Oct. 13, 2022 (GLOBE NEWSWIRE) - ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2023 on Thursday, October 27, 2022, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. Other forward-looking and material information may also be discussed during this webcast. Earnings webcast details: • Location: http://investor.resmed.com • Date: Thursday, October 27, 2022 • Time: 1:30 p.m. PDT / 4:30 p.m. EDT • International: London, Thursday, October 27, 9:30 p.m. BST Sydney, Friday, October 28, 7:30 a.m. AEDT Please note that ResMed does not use outside phone lines to access the earnings call. A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately two hours after the webcast and


Source:ResMed
ResMed Inc. – Consensus Indicates Potential 18.6% Upside
Sep 26, 2022 12:40pm

ResMed Inc. found using ticker (RMD) now have 6 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 276 and 222 with the average target price sitting at 253.33. With the stocks previous close at 213.69 this is indicating there is a potential upside of 18.6%. The day 50 moving average is 230.48 and the 200 day moving average is 230.45. The market cap for the company is $31,410m. Visit the company website at: https://www.resmed.com [stock_market_widget type="chart" template="basic" color="green" assets="RMD" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $37,236m based on the market concensus. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.


Source:DirectorsTalk